Second Sight Medical Products
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch EYES and buy or sell other stocks, ETFs, and their options commission-free!About EYES
Second Sight Medical Products, Inc. engages in the development, manufacture, and marketing of implantable visual prosthetics. Its product, the Argus II Retinal Prosthesis System, treats outer retinal degenerations, such as retinitis pigmentosa, also referred to as RP.
CEOJonathan Will McGuire
CEOJonathan Will McGuire
Employees123
Employees123
HeadquartersSylmar, California
HeadquartersSylmar, California
Founded1998
Founded1998
Employees123
Employees123
EYES Key Statistics
Market cap515.84M
Market cap515.84M
Price-Earnings ratio0.00
Price-Earnings ratio0.00
Dividend yield—
Dividend yield—
Average volume297.74K
Average volume297.74K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.20
52 Week high$1.20
52 Week low$0.64
52 Week low$0.64
Stock Snapshot
The current Second Sight Medical Products(EYES) stock price is $4.14, with a market capitalization of 515.84M. The stock trades at a price-to-earnings (P/E) ratio of 0.00 and offers a dividend yield of 0.0%.
On 2025-12-13, Second Sight Medical Products(EYES) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Second Sight Medical Products(EYES) stock has reached 0, versus its average volume of 297.74K.
Over the past 52 weeks, Second Sight Medical Products(EYES) stock has traded between a high of $1.20 and a low of $0.64.
Over the past 52 weeks, Second Sight Medical Products(EYES) stock has traded between a high of $1.20 and a low of $0.64.